Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,266 recruiting studies in this area right now.
By phase
- Not applicable9,566
- Phase 24,421
- Phase 12,682
- Phase 1/Phase 21,651
- Phase 31,398
- Phase 2/Phase 3282
- Phase 4266
Top conditions
- Breast Cancer1,204
- Prostate Cancer647
- Cancer636
- Colorectal Cancer480
- Lung Cancer419
- Ovarian Cancer341
- Multiple Myeloma333
- Pancreatic Cancer289
- Gastric Cancer284
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor246
- Advanced Solid Tumor233
- Head and Neck Cancer227
- Cervical Cancer224
- Endometrial Cancer213
- Advanced Solid Tumors205
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center292
- Sun Yat-sen University275
- Mayo Clinic238
- City of Hope Medical Center147
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- AstraZeneca133
- Ruijin Hospital127
Where studies are running
- California1,416
- Texas630
- Arizona510
- Florida433
- Alabama427
- New York406
- Massachusetts341
- Maryland331
- New Jersey276
- Pennsylvania235
Recruiting studies20,266 total
- NCT07118813Recruiting
AI predicts kidney cancer surgery outcomes
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
Wuhan, HubeiAges 18 years+ - NCT07124546Recruiting
Acceptance and commitment therapy for cancer distress
This trial tests a type of counseling called acceptance and commitment therapy (ACT) to help people with incurable cancer feel less distressed. It is done in a group over the internet, so you can join from home.
Rochester, MinnesotaAges 18 years+ - NCT07117058Recruiting
Anxiety and depression screening for young cancer survivors
This study tests a quick tool to identify anxiety or depression in children, teens, and young adults who have finished intensive cancer treatment and are now in remission. It aims to help doctors provide better mental health support.
AngersAges 7–25 - NCT07116161Recruiting
Exercise and counseling for fatigue in female breast cancer patients
This trial tests if combining exercise with cognitive behavioral therapy (counseling) can help reduce fatigue in women with breast cancer. You may be able to join if you have completed your initial treatments and still feel tired.
SingaporeAges 21 years+ - NCT07115667RecruitingPhase 2
Radiation and antibody therapy for bone plasmacytoma
This trial tests a new combination of radiation therapy and a bispecific antibody (a drug that helps your immune system attack cancer cells) for people with a single bone plasmacytoma that has only a small number of abnormal cells in the bone marrow. It aims to see if this approach can control the disease better than radiation alone.
TianjinAges 18–78 - NCT07120633Recruiting
CAR-T cell therapy plus BTK inhibitor for high-risk CLL/SLL
This trial tests a new approach for people newly diagnosed with high-risk CLL or SLL. It combines your own immune cells (CAR-T cells) with a targeted pill (BTK inhibitor) to try to attack the cancer more effectively. It may be an option if you have certain high-risk genetic features and haven't had prior chemotherapy.
Xuzhou, JiangsuAges 18 years+ - NCT07117227Recruiting
Study to test a kidney cancer prediction model
This study is checking how well a model can predict the outcomes for people with kidney cancer who have had surgery. It looks at your medical records after surgery to help doctors better understand your recovery and future risks.
Beijing, Beijing MunicipalityAges 18–80 - NCT07118683Recruiting
Brazilian health study for people with HIV or AIDS
This study is creating a record of chronic health conditions (like heart disease, diabetes, or high blood pressure) in people living with HIV or AIDS in Brazil. Joining helps researchers better understand and care for the health needs of people like you.
Goiânia, GoiásAges 18 years+ - NCT07117890RecruitingPhase 2
Sunvozertinib for untreated NSCLC with EGFR rare mutations
This trial tests a drug called sunvozertinib in people with advanced non-small cell lung cancer (NSCLC) that has not been treated yet. It is for those who have certain uncommon changes in the EGFR gene. The drug may shrink tumors or stop them from growing.
ShanghaiAges 18 years+ - NCT07124754Recruiting
Predicting lymph node spread in early stomach cancer
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
Shijiazhuang, None SelectedAges 18 years+ - NCT07122674Recruiting
New PET scan for blood cancers
This study tests a new PET scan method (using a special tracer called 18F-Pentixafor) to see if it can better find and track blood cancers. It may help your doctors get more detailed images with less radiation.
Hangzhou, ZhejiangAges 18–80 - NCT07120178Recruiting
Imaging and outlook for colored eye growths in children
This study looks at how colored growths on the front of the eye (called pigmented tumors) are imaged and how they change over time in children. Researchers want to understand these growths better to improve care.
Saint-EtienneAges Up to 18 years - NCT07117851RecruitingPhase 2
Study of disitamab vedotin and bicalutamide for HER2/AR-positive Paget's disease
This trial tests a combination of two drugs: disitamab vedotin (which attacks cancer cells with a certain protein) and bicalutamide (which blocks male hormones that can fuel cancer growth). It is for people with Paget's disease that has spread or cannot be removed, and whose cancer cells have specific protein markers called HER2 and AR.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07120529Recruiting
Comparing two types of hysterectomy for early cervical cancer
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
BialystokAges 18–85 - NCT07117864Recruiting
T-DXd with brain radiation for HER2+ breast cancer
This trial tests a new combination of a targeted drug (T-DXd) with brain radiation for women with breast cancer that has spread to the brain and is HER2-positive or HER2-low. The goal is to see if this approach is safe and works better than radiation alone.
Beijing, Beijing MunicipalityAges 18–75 - NCT07118436Recruiting
Liquid biopsy during PSMA radiation therapy
This trial studies blood tests (liquid biopsies) in men with metastatic prostate cancer that no longer responds to hormone therapy or chemotherapy and who are receiving a type of radiation therapy called PSMA RLT. The goal is to see if these blood tests can provide useful information about the cancer and treatment response.
AugsburgAges Any age - NCT07122713Recruiting
Radiation therapy for inoperable breast cancer
This trial tests whether definitive radiation therapy can effectively treat breast cancer that cannot be surgically removed. It may be an option for people whose cancer is inoperable or who choose not to have surgery.
Stony Brook, New YorkAges 18 years+ - NCT07125183RecruitingPhase 2
Weekly chemo for advanced leiomyosarcoma in older adults
This trial tests whether weekly doxorubicin is effective and tolerable for people aged 65 and older with advanced or metastatic leiomyosarcoma. It may be a good option if you have not had this type of chemo before.
Aurora, ColoradoAges 65–100 - NCT07125573Enrolling by invitation
Esketamine and dexmedetomidine for recovery after lung surgery
This trial tests if adding two medicines (esketamine and dexmedetomidine) during your thoracoscopic (keyhole) lung surgery helps you recover better and feel less discomfort afterward.
Kunming, YunnanAges 18–65 - NCT07125547RecruitingPhase 2
Immunotherapy and chemo before surgery for ureteral cancer
This trial tests a combination of immunotherapy (tislelizumab) and chemotherapy (nab-paclitaxel) given before surgery for ureteral cancer. The goal is to see if the treatment shrinks the tumor and makes the surgery more effective.
Tianjin, Outside U.S.Ages 18 years+ - NCT07122245Recruiting
Studying lung cancer in women
This study looks at the characteristics and trends of primary lung cancer in women diagnosed over the past 10 years. It helps researchers understand more about how lung cancer affects women.
Al MansurahAges Any age - NCT07118202Recruiting
TheraBionic device for advanced liver cancer
This trial tests a device called TheraBionic P1 for people with advanced liver cancer that has not responded to other treatments. It may be an option if you have tried at least two prior therapies or cannot take standard treatments.
Bay City, MichiganAges 22 years+ - NCT07120906Enrolling by invitation
Augmented reality guidance for MRI liver procedures
This study tests a new augmented reality system to help doctors place needles in the liver during MRI scans for biopsies or ablation (heat to destroy tumors). The goal is to see if it improves accuracy and speed.
Jacksonville, FloridaAges 18–90 - NCT06902051Recruiting
Side-lying position for left breast cancer radiation
This trial tests whether lying on your right side during radiation therapy for left breast cancer can reduce side effects. It is for women who have had surgery for newly diagnosed left breast cancer and need radiation.
Guangzhou, Guangdong ProvinseAges 18–70
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,266 recruiting oncology studies from the U.S. registry right now, out of 30,859 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.